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ABSTRACT
Introduction: Heart failure is a clinical syndrome characterized by sympathetic/
renin-angiotensin system activation, besides parasympathetic activity attenuation. 
In the initial phase of HF, following a myocardial infarction, there is impairment of 
the ventricular function and this can be influenced by the myocardium ischemia area 
in addition to alteration in the autonomic control of the heart. The aim of this study 
is to evaluate the hemodynamic responses and autonomic nervous system and its 
associations in infarcted rats by left coronary artery ligation.
Methods: Forty male rats were submitted to left coronary artery ligation: infarcted 
animals with fifteen days from cardiac surgery (I15), infarcted animals with thirty days 
from cardiac surgery (I30) and sham-operated groups (S15 and S30), with 10 animals 
in each group. Basal hemodynamic data and heart rate variability (spectral analysis) 
were evaluated.
Results: Compared to control groups, the infarcted rats demonstrated the following 
complications: a) cardiac hypertrophy (I30); b) pulmonary congestion (I30); c) mean 
arterial pressure (MAP), systolic arterial pressure (SAP) and diastolic arterial pressure 
(DAP) reduction; d) left ventricular systolic pressure (LVSP) reduction and left ventricular 
end-diastolic pressure (LVEDP) rise; e) contractile (+dP/dt) and relaxation derivatives 
(-dP/dt) reduction; f) sympathetic cardiac activity increase, and parasympathetic 
cardiac activity reduction (I30).
Conclusion: Our study shows that the infarcted animals presented left ventricular 
dysfunction, which was influenced by the infarct size. In addition, impairment of 
autonomic control was present only in the animals belonging to the I30 group, probably 
due to the degree of cardiac decompensation and disease progression.
Keywords: Heart failure; myocardial infarction; heart rate variability
Heart failure is a major and growing public health problem in the United 
States1. Despite the progress made with medical and device-based therapies, 
the number of annual hospital admissions due to heart failure continues 
to increase, posing a substantial burden on healthcare resources2. Heart 
failure is characterized by neurohumoral adaptations such as sympathetic 
nervous system and renin-angiotensin system activation, increased plasma 
anti-diuretic hormone, and parasympathetic withdrawal, which are implicated 
in the progressiveness of the syndrome3.
Heart failure is a multifactorial systemic disease in which, after cardiac 
injury, structural, neurohumoral, cellular, and molecular mechanisms are 
activated and act as a network to maintain physiological functioning. These 
processes lead to excessive volume overload, increased sympathetic activity, 
circulation redistribution, and result in different parallel developing clinical 
signs and symptoms4,5.
Coronary artery disease is an important cause of heart failure, accounting 
for two-thirds of patients with left ventricular systolic dysfunction. In most of 
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these cases, it is a consequence of a myocardial 
infarction (MI), a situation that marks the exact 
moment of the myocardium damage6-8. Although 
there is no animal model that can mimic entirely the 
pattern of human heart failure, the most commonly 
used animal model to study this condition is the 
complete coronary occlusion by ligation9.
The interactions between the heart and the 
autonomic nervous system (ANS) have been known 
for several decades. The ANS has two primary 
components: the sympathetic and parasympathetic 
systems. The sympathetic nervous system (SNS) is 
the cardio-stimulatory pathway, which increases heart 
rate and force of contraction, while the parasympathetic 
nervous system (PNS) is the cardio-inhibitory pathway 
and acts through reducing the heart rate, blood 
pressure, and contractility10. The importance of slowing 
down heart failure progressiveness brought interest in 
the comprehension of pathophysiologic mechanisms 
responsible for the imbalance between sympathetic 
and parasympathetic systems in this syndrome11. 
In a heart that becomes insufficient, as angiotensin 
II and norepinephrine increase, the inhibitory input 
from the baroreceptor afferent vessels decreases 
while the excitatory input increases, resulting in a 
sympathetic and parasympathetic tonus imbalance3. 
Data from animal and human studies show that 
the parasympathetic activity is attenuated in heart 
failure. Defective cardiac parasympathetic control 
in patients with heart disease and augmentation of 
the sympathetic activity appears to be related to the 
parasympathetic withdrawal. In addition, the cardiac 
parasympathetic tonus has an inhibitory effect upon 
sympathetic activity12.
Experimental evidence for an association between 
pathological conditions, such as acute MI and 
heart failure, and signs of increased sympathetic or 
reduced vagal activity has aroused interest in the 
development of quantitative markers of autonomic 
activity13. The heart rate variability (HRV) is one of the 
techniques used in its evaluation, which describes the 
oscillations in the interval between consecutive heart 
beats (RR interval), as well as the oscillations between 
consecutive instantaneous heart rates. Higher HRV 
is a signal of good adaptation and characterizes a 
healthy person with efficient autonomic mechanisms, 
while lower HRV is frequently an indicator of abnormal 
and insufficient adaptation of the ANS, provoking a 
poor physiological function14.
We hypothesized that acute MI, early and late, 
leads to changes in the autonomic nervous system. 
To investigate this hypothesis, this study evaluates the 
hemodynamic responses and autonomic imbalance 
through the evaluation of HRV in infarcted rats after 
left coronary artery ligation.
METHODS
Animals and Experimental Procedures
Experiments were performed on male Wistar rats 
(250-300g) from the Animal House of the Universidade 
Federal do Rio Grande do Sul, Porto Alegre, Brazil. 
The animals received rat chow and water ad libitum 
and were maintained on a 12:12-h light-dark cycle. 
They were acclimatized for one week, then fasted 
overnight and submitted to the surgical procedures 
as described below.
The experimental protocol was approved by the 
Institutional Animal Care and Use Committee of 
the Instituto de Ciências Básicas da Saúde of the 
Universidade Federal do Rio Grande do Sul, and this 
investigation was conducted in accordance with the 
Guide for the Care and Use of Laboratory Animals: 
National Research Council15.
The animals were randomly assigned to sham 
(with 15 or 30 days from the sham surgical procedure; 
S15 and S30) or infarct group (with 15 or 30 days 
from myocardial infarction surgery; I15 and I30), 
each with 10 animals.
In order to detect a difference in the low 
frequency/high frequency ratio (LF/HF), that 
indicates the sympathovagal balance, between 
groups of 11 NU (normalized units), considering a 
standard deviation of 0.06, power of 90% and level 
of significance of 5%, 10 animals were included per 
group (n=40 animals). The sample size was based 
on the findings of Mostarda et al.16.
Coronary Artery Ligation Surgery
Myocardial infarction was induced in rats anesthetized 
by intraperitoneal (i.p.) injection of 80-mg/kg ketamine 
(Parke-Davis, Ann Arbor, MI) and 12-mg/kg xylazine 
(Bayer, Newhaven, CT). After intubation, animals 
were ventilated with positive-pressure with room 
air (2.5 mL/kg), at the respiratory rate of 65 rpm 
with a pressure-cycled rodent ventilator (Harvard 
Apparatus, Model 683, Holliston, MA). For induction of 
myocardial infarction, a 2-cm left lateral thoracotomy 
was performed in the third intercostal space and the 
left anterior descending coronary artery was occluded 
with a single nylon (6.0) suture at approximately 
1 mm from its origin below the tip of the left atrium, 
as previously described6. The chest was closed 
with silk suture. The animals were maintained in the 
ventilator until recovery. All rats received one dose 
of antibiotic (25 mg/kg cephalotin - Keflin Neutro).
Arterial and Venous Catheterization
Fourteen and 29 days after cardiac surgery, the 
animals were anesthetized with ketamine (80 mg/kg, i.p.) 
and xylazine (12 mg/kg, i.p.). Two Tygon catheters 
http://seer.ufrgs.br/hcpaClin Biomed Res 2018;38(2)134
Nascimento et al.
(P10) filled with saline were introduced into the right 
femoral artery and vein for direct measurements of 
blood pressure and drug administration, respectively. 
The catheters were exteriorized through the back 
of the neck.
Hemodynamic Function Assessment
Arterial Pressure (AP) and left ventricular 
pressure records
One day after the vessel catheterization 
(I15: 15th and I30: 30th day) the rats, in a conscious state 
and moving freely, had their AP recorded for 15 minutes 
through a connection between femoral artery catheter 
and a pressure transducer (Strain-Gauge - Narco 
Biosystem Miniature Pulse Transducer RP-155, 
Houston, Texas, USA). The transducer was connected 
to a sign amplifier (Pressure Amplifier HP 8805C) 
and a 16-channel analog-to-digital interface 
(CODAS - Data Acquisition System, PC 486), and 
continuously sampled (2 kHz) in an IBM/PC.
The rats were anesthetized with pentobarbital 
sodium (40 mg/kg, i.v.) to introduce a polyethylene 
catheter (P50) into the left ventricle through the right 
carotid artery. The correct position of the catheter was 
determined by the observation of the left ventricular 
pressure wave depicted on the computer screen. 
After 5 minutes, the ventricular pressure was registered 
for 5 minutes using the same system/software 
described above for AP evaluation. The higher left 
systolic ventricular pressure (LSVP) was determined 
by detection of maximum and minimum values of 
the curve pressure, beat by beat, providing systolic 
ventricular pressure. The left ventricular end-diastolic 
pressure (LVEDP) was determined by manual 
detection of the inflection point of the left ventricular 
diastolic pressure curve. The contractile (+dP/dt) and 
relaxation (-dP/dt) derivatives were obtained from 
left ventricular pressure curve and its maximum and 
minimum values, beat-by-beat.
Heart Rate (HR) Variability
Beat-by-beat values of systolic, diastolic and mean 
AP were identified from the AP record, from which 
pulse interval (PI) and HR were calculated as the 
interval between successive systolic pressure values 
by using the computer software (CODAS Dataq, Inc). 
The computer program automatically calculated the 
power spectral density (PSD) by using a maximal 
entropy method. Derived PSD of R-R interval variability 
contained two major components in power: a low 
frequency (LF, 0.05 to 0.15 Hz) and a high frequency 
(HF, 0.15 to 1.0 Hz) band17. The measurement of 
LF and HF components is usually made in absolute 
values of power (milliseconds squared). However, 
LF and HF may also be measured in normalized 
units, which emphasizes the controlled and balanced 
behavior of the two branches of the autonomic nervous 
system13. The high frequency band was used as an 
index of parasympathetic modulation and the low 
frequency band was used as an index of sympathetic 
activity. The ratio of low to high frequency (LF/HF) 
bands was used as an index of sympathetic and 
parasympathetic balance13,17.
Morphometric Evaluation
Immediately after the procedures described above, 
the rats were killed by a pentobarbital overdose. 
The heart was removed, the atria were separated from 
the ventricles. The right ventricle, left ventricle, and 
interventricular septum were dissected, separated, 
and weighed. The total weight of the heart and each 
part were measured. The cardiac, right and left 
hypertrophy index (mg/g) were respectively calculated 
by the ratio of heart weight and body weight, right 
ventricle weight and body weight, and left weight 
and body weight6.
Pulmonary and hepatic congestion were evaluated 
by dissecting and weighing these organs. The ratio of 
wet weight and body weight were used to determine 
the congestion18.
The infarcted size was obtained by manual 
planimetry, isolating the left ventricle scar. The infarcted 
and non-infarcted areas of the left ventricle, in 
addition to the right ventricle area, were placed on 
a paper and drawn. Afterward, the paper was cut 
and weighed. The infarcted size was calculated by 
the ratio of infarcted area mass and the sum of the 
left and right ventricle mass19.
Statistical Analysis
Data are reported as mean ± SD. Repeated 
measures two-way ANOVA was performed, with 
Student-Newmann-Keuls as post-test. The Pearson’s 
correlation coefficient was used for the correlations 
between variables. Differences were considered to be 
significant at p<0.05. The statistical analysis used the 
GraphPad Instat software, version 3.0 for Windows 
95 (GraphPad Software, San Diego, California, USA).
RESULTS
The infarct size was determined as a percentage of 
the left ventricle total area, as an indication of ventricular 
dysfunction. The infarct size was 35.1 ± 9.1% in the 
I15 group and 31.7 ± 11.5% in the I30 group, which 
were similar (p=0.474).
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All groups had similar body weight at the beginning 
of the study (~240g) (p=0.109). Baseline cardiovascular, 
biometric, and morphometric data are presented 
in Table 1. At the end of 15 and 30 days from the 
surgical procedures, body weight was similar between 
all groups, infarcted and sham animals (p=0.885). 
The heart weight/body weight index demonstrates that 
the 30-day infarcted animals had cardiac hypertrophy 
(2.5 ± 0.1, 2.65 ± 0.2 and 3.0 ± 0.2 mg/g in S, 
I15 and I30 groups, respectively, p<0.001) and the wet 
lung /body weight ratio showed they had pulmonary 
congestion (5.6 ± 1, 6.3 ± 1.4 and 7.5 ± 2.7 mg/g in 
S, I15 and I30 groups, respectively, p<0.05).
Table 1 also shows that the heart rate was similar 
between groups, as well as the systolic, diastolic and 
mean arterial pressure at baseline, which were reduced 
in the infarcted vs. control rats (p<0.001). The LVSP 
was diminished 15 and 30 days after coronary artery 
ligation (p<0.01 and p<0.05 vs. S, respectively). 
The LVEDP was increased in both periods of evaluation 
(I15 and I30 groups vs. S with p<0.05 and p<0.01, 
respectively). Ventricular contractile and relaxation 
derivatives, expressed by the +dP/dt and -dP/dt, 
were both reduced in I15 and I30 vs. S (p˂0.001).
There were positive correlations between cardiac 
hypertrophy and the infarct size (r=0.4, p=0.0048) 
(Figure 1) and +dP/dt and LVSP (r=0.7, p<0.0001) 
(Figure 2). Otherwise, there were negative correlations 
between -dP/dt and LVEDP (r=-0.3, p=0.0009) (Figure 3), 
Table 1: Biometric, Morphometric and Hemodynamic Indexes of Control, I15 and I30 Animal Groups.
Sample Size (n=40) S15 (n=10) S30 (n=10) I15 (n=10) I30 (n=10)
Initial Body Weight (g) 243.7±27 239.3±24.7 251.6±31.5 232.2±18.5
Final Body Weight (g) 276.4±35.2 281.4±40.2 274±37.7 282.2±52.6
Infarct Size (%) 35.1±9.1 31.7±11.5
Heart Weight/Body Weight (mg/g) 2.58±0.2 2.54±0.1 2.65±0.2 3±0.2§
Left Ventricle Weight/ Body Weight (mg/g) 2.06±0.1 2.03±0.1 2.17±0.2* 2.25±0.2‡
Right Ventricle Weight/ Body Weight (mg/g) 0.52±0.07 0.5±0.09 0.57±0.1 0.68±0.2‡*
Wet Lung Weight/Body Weight (mg/g) 5.7±0.6 5.2±0.7 6.3±1.4 7.5±2.7*
MAP (mmHg) 102.3±5 105.9±5.6 91±10§ 91.7±7§
SAP (mmHg) 122.1±5.9 125.9±6.5 107.2±13§ 110.7±10§
DAP (mmHg) 84.0±5.8 87.1±6 79.6±5§ 79.9±5§
HR (bpm) 333.8±24.1 340.5±23.1 342.6±24 347.7±39
LVSP (mmHg) 161.4±3.9 162.7±4.2 133.0±3‡ 150.6±4*
LVEDP (mmHg) 1.3±2.5 0.33±2.4 7.87±3* 7.71±2‡
–dP/dt (mm Hg/s) -6857.12±398.7 -7011.38±398.93 -4854.17±258.3§ -5488.55±259.8§
+dP/dt (mmHg/s) 8101.18±300.8 8029.29±300.3 5811.65±257.7§ 6744.72±298.3§
Data are presented as mean ± SD. MAP: mean arterial pressure; SAP: systolic arterial pressure; DAP: diastolic arterial pressure; HR: heart 
rate; LSVP: left systolic ventricular pressure; LVEDP: left ventricular end-diastolic pressure; –dP/dt: relaxation derivative; +dP/dt: contractility 
derivative; §p<0.001 vs. S; ‡p<0.01 vs. S; *p<0.05 vs. S; *p<0.05 between infarcted groups (two-way ANOVA with Student-Newmann-Keuls 
as post-test).
Figure 1: Correlation between cardiac hypertrophy and the 
infarct size in I15 (♦) and I 30 (▲) groups. r=0.4, p=0.0048. 
(Pearson’s Correlation).
Figure 2: Correlation between LVSP (Left Ventricle Systolic 
Pressure) and +dP/dt (Left Ventricle Contractile Derivate) 
in S (◊), I15 (♦) and I30 (▲) groups. r=0.7, p<0.0001 
(Pearson’s Correlation).
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infarct size and MAP (r=-0.6, p=0.0222) (Figure 4), 
infarct size and SAP (r=-0.6, p=0.01) (Figure 5), infarct 
size and LVSP (r=-0.3, p<0.0001) (Figure 6), infarct 
size and -dP/dt (r=-0.6, p˂0.0001) (Figure 7), and 
infarct size and +dP/dt (r=-0.5, p˂0.0001) (Figure 8).
The data above confirm the effectiveness of 
this animal model of myocardial ischemia and 
the subsequent morphological and hemodynamic 
alterations following myocardial infarction.
The biometric and morphometric variables 
between the S15 and S30 groups did not show 
statistical differences and, therefore, the data of 
the spectral analysis of these animals were placed 
together in a single sham group. Figure 9 shows the 
results of the analysis of the heart rate variability. 
The I30 group had a significant increase in the 
LF(I30: 68±3 vs. S: 45±4.8 and I15: 53.6±9.8 NU, p<0.01) 
and a reduction in the HF (I30: 32±3 vs. S: 55±4.8 and 
I15: 46.3±9.8 NU, p<0.05) components (Panel A and B). 
The LF/HF ratio was higher in the I30 group, compared 
to the S and I15 groups (I30: 2.2±0.3 vs. S: 0.8±0.2 
and I15: 1.2±0.4 NU, p<0.01) (Panel C).
Figure 3: Correlation between -dP/dt (Left Ventricle Relaxation 
Derivate) and LVEDP (Left Ventricle End-Diastolic Pressure) 
in S (◊), I15 (♦) and I30 (▲) groups. r=-0.3, p=0.0009 
(Pearson’s Correlation).
Figure 4: Correlation between infarct size and MAP (Mean 
Arterial Pressure) in I15 (♦) and I30 (▲) groups. r=-0.6, 
p=0.0222 (Pearson’s Correlation).
Figure 5: Correlation between infarct size and SAP (Systolic 
Arterial Pressure) in I15 (♦) and I30 (▲) groups. r=-0.6, 
p=0.01 (Pearson’s Correlation).
Figure 8: Correlation between infarct size and +dP/dt 
(Left Ventricle Contractile Derivate) in I15 (▲) and I30 (▲) groups. 
r=-0.5, p˂0.0001) (Pearson’s Correlation).
Figure 7: Correlation between infarct size and -dP/dt (Left 
Ventricle Relaxation Derivate) in I15(▲) and I30 (▲) groups. 
r=-0.6, p˂0.0001 (Pearson’s Correlation).
Figure 6: Correlation between infarct size and LVSP (Left 
Ventricle Systolic Pressure) in I15 (♦) and I30 (▲) groups. 
r=-0.3, p<0.0001 (Pearson’s Correlation).
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DISCUSSION
This study shows depressed HRV after MI, which 
may reflect a decrease in vagal activity directed to 
the heart, leading to the prevalence of sympathetic 
mechanisms.
Myocardial Infarction/Heart Failure Model
The left coronary artery ligation is the most 
used experimental model for the induction of heart 
failure. This model produces marked left ventricular 
dysfunction that is directly related to the size of the 
infarcted area.
One of the pioneer studies of Pfeffer et al.6 
demonstrated that only rats with infarcts with more 
than 47% of the left ventricle were associated with 
overt depression of left ventricular performance. 
However, in the present study, a moderate infarct 
size (31-46%) was able to lead an elevated LVEDP 
and reduced in the MAP, -dP/dt and +dP/dt, which 
confirms the effectiveness of myocardial infarction 
in leading to hemodynamic changes.
In all groups submitted to coronary artery ligation, 
the LVEDP, one of the most sensitive criteria of 
decreased left ventricular function6,18 was much 
higher compared to the S group, as shown earlier20. 
In addition, the heart weight/body weight and the 
lung weight/body weight indexes were higher in the 
I30 group, another characteristic that confirms moderate 
to severe impaired left ventricular systolic function. 
When left ventricular filling pressure is elevated, right 
ventricular systolic pressure increases to maintain 
the pressure gradient across the pulmonary bed. 
Hence, the elevation of LVEDP produced by extensive 
infarction appears to result in the right ventricular 
hypertrophy21, as demonstrated in I30 animals. 
In fact, it could explain the presence of pulmonary 
congestion only in this group of animals, while in the 
initial phase after MI (I15 group), the heart was still 
able to maintain its function.
Also, the groups of infarcted animals showed 
lower –dP/dt and +dP/dt compared to the S group. 
A positive correlation was observed between the 
infarct size and cardiac hypertrophy, in line with 
previous observations that the large and transmural 
myocardial infarctions lead to important changes in 
the architecture of infarcted and non-infarcted zones 
(ventricular remodeling)6.
There was an inverse and significant correlation 
between the infarct size and the -dP/dt and +dP/dt, 
demonstrating that the larger infarction hearts have a 
lower ventricular capacity of relaxation and contractility. 
A positive and significant correlation between +dP/dt 
and LVSP was demonstrated; however, there was an 
inverse and significant correlation between cardiac 
hypertrophy and LVSP. Pathological hypertrophy is 
an adaptive response to hemodynamic overload, as 
it occurs after myocardial infarction in humans, but 
this response can result in left ventricular function 
deterioration, with impairment of ventricular relaxation 
Figure 9: Heart rate variability: low frequency (A) and high frequency (B) components; low frequency/high frequency ratio 
(C). Data are presented as frequency component, as mean ± SD. *p<0.05 from I30 vs. I15 and sham groups (two-way 
ANOVA, with Student-Newmann-Keuls as post-test).
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(diastolic dysfunction) and contractility (systolic 
dysfunction)22.
The LVSP, SAP, DAP and MAP were reduced 
in both infarcted groups, according to other studies 
and to our own previous data22,23. Acute MI causes 
a reduction in the pumping capacity of the heart, 
which reduces cardiac output and blood pressure. 
These changes are directly related to the area of the 
left ventricle affected by the ischemic damage6,24, 
corroborating our findings.
The methodological limitation of this study - not 
having performed a more accurate assessment of 
myocardial infarct size, such as an echocardiographic 
evaluation - was overcome by the characteristic 
hemodynamic and morphometric changes described 
above, which clearly show left ventricular dysfunction 
in infarcted animals. Another limitation of this study is 
the mortality rate associated with this experimental 
model of myocardial infarction. These data were not 
evaluated in the study, since our group has used 
this procedure with a mortality of 40-50%, which is 
in accordance with the literature6,18.
In summary, these observations clearly demonstrate 
the induction of early heart failure, between 15 and 
30 days after myocardial infarction.
Autonomic Dysfunction in the Myocardial 
Infarction/Heart Failure Model
The spectral analysis of HRV is a method that can 
provide data on sympathetic and parasympathetic 
balance. While the sympathetic activity increases 
the frequency of cardiac beats, the parasympathetic 
activity is responsible for reducing the heart rate13.
A reduced HRV has been observed consistently 
in patients with cardiac disease since this condition is 
characterized by a sympathetic hyperactivity25.
Evidence has been provided that both the baroreflex 
control of HR and the HRV may be impaired after 
myocardial infarction, identifying subgroups of patients 
with a high susceptibility to malignant ventricular 
arrhythmias26.
Previously, we show that the baroreflex control 
of HR is normal in anesthetized rats 30 days after a 
myocardial infarction and that these rats had higher 
spontaneous baroreceptor sensitivity of HR when 
submitted to exercise training compared to untrained 
rats27,28. Also, the sympathetic tone was higher during 
the tachycardic phase after myocardial infarction. 
In a time-course evaluation, it was shown that HR 
normalization paralleled the progressive reduction 
of sympathetic tone, so the changes in HR after 
coronary artery ligation seemed to reflect the degree 
of sympathetic efferent activity during infarct healing17. 
In fact, our study did not evaluate the baroreflex 
control of HR.
In the present study, the spectral profile shows that 
in the 30-day, but not in the 15-day infarcted animals, 
there was an increase in the sympathetic activity 
(LF and LF/HF) but a reduction in the parasympathetic 
activity (HF).
The impairment of sympathovagal balance after 
MI seems to be transient. A gradual recovery of the 
normal autonomic activity in the heart after MI has 
been demonstrated. Aires et al.29 evaluated the time 
course of changes in autonomic balance. The HF 
component obtained from HRV was significantly 
reduced in the acute phase after infarction. Unlike our 
data, the parasympathetic activity was progressively 
recovered in the groups of animals studied 7 and 28 days 
after coronary ligation, which seems to be related to 
the presence of a consolidated scar. The authors 
demonstrated a significant reduction in LF component 
analyzed by blood pressure (BP) variability, where this 
component is more representative of the baroreflex 
sensitivity.
In a heart failure model in dogs, increased sympathetic 
efferent flux and reduced parasympathetic activity 
were observed (HRV was evaluated by spectral 
analysis). During the early asymptomatic phase of 
cardiac dysfunction, the HF component decreased 
markedly as decreased the left ventricular peak +dP/dt. 
The LF component and the LF/HF ratio showed a 
gradual increase as symptoms of heart dysfunction 
progressed. According to the authors, the LVSP and 
+dP/dt decay could probably result in attenuated stimuli 
to the carotid sinus baroreceptor. These diminished 
inputs to baroreceptors could potentially inhibit tonic 
vagal efferent activity to the heart, thereby decreasing 
HR variability17. Other authors have shown a reduced 
parasympathetic activity at the same time of ventricular 
dysfunction, with no clinical evidence of heart failure 
in a similar animal model30. These studies corroborate 
our results since only the animals in the I30 group 
demonstrated a significant attenuation in the HF 
component in addition to the presence of congestive 
signs and cardiac decompensation.
Some questions remain to be explored, such as 
the most appropriate method for HRV analysis and, 
primarily, the time frame and the pathophysiological 
mechanism involved.
In summary, this study demonstrates that the 
infarcted animals presented left ventricular dysfunction 
which was influenced by the infarct size. In addition, 
impairment of autonomic control was demonstrated 
only in the animals belonging to the I30 group, probably 
due to the degree of cardiac decompensation and 
disease progression.
Funding
Conselho Nacional de Desenvolvimento Científico 
e Tecnológico (CNPq).
Conflicts of Interest
The authors declare no conflicts of interest.
http://seer.ufrgs.br/hcpa Clin Biomed Res 2018;38(2) 139
Hemodynamic changes and autonomic nervous system in heart failure
REFERENCES
1. Yancy CW, Jessup M, Bozkurt B, 
Butler J, Casey DE JR, Drazner 
MH, et al. 2013 ACCF/AHA guideline 
for the management of heart failure: 
a report of the American College of 
Cardiology Foundation/American 
Heart Association Task Force on 
Practice Guidelines. J Am Coll Cardiol. 
2013;62(16):e147-239. http://dx.doi.
org/10.1016/j.jacc.2013.05.019. 
PMid:23747642.
2. Hunt SA, Abraham WT, Chin MH, 
Feldman AM, Francis GS, Ganiats 
TG, et al. 2009 focused update 
incorporated into the ACC/AHA 
2005 Guidelines for the Diagnosis 
and Management of Heart Failure 
in Adults: a report of the American 
College of Cardiology Foundation/
American Heart Association Task 
Force on Practice Guidelines: 
developed in collaboration with 
the International Society for 
Heart and Lung Transplantation. 
Circulation. 2009;119(14):e391-
479. http://dx.doi.org/10.1161/
CIRCULATIONAHA.109.192065.
3. Floras JS. Sympathetic activation 
in human heart failure: diverse 
mechanisms, therapeutic 
opportunities. Acta Physiol 
Scand. 2003;177(3):391-8. http://
dx.doi.org/10.1046/j.1365-
201X.2003.01087.x. PMid:12609011.
4. Tanai E, Frantz S. Pathophysiology 
of heart failure. Compr Physiol. 
2015;6(1):187-214. http://dx.doi.
org/10.1002/cphy.c140055. 
PMid:26756631.
5. Lazzarini V, Mentz RJ, Fiuzat M, 
Metra M, O’Connor CM. Heart failure 
in elderly patients: distinctive features 
and unresolved issues. Eur J Heart 
Fail. 2013;15(7):717-23. http://
dx.doi.org/10.1093/eurjhf/hft028. 
PMid:23429975.
6. Pfeffer MA, Pfeffer JM, Fishbein 
MC, Fletcher PJ, Spadaro J, Kloner 
RA, et al. Myocardial infarct size 
and ventricular function in rats. Circ 
Res. 1979;44(4):503-12. http://
dx.doi.org/10.1161/01.RES.44.4.503. 
PMid:428047.
7. Clausell N, Ribeiro JP. In search 
of new paradigms for the 
management of heart failure. Arq 
Bras Cardiol. 1998;71(4):563-
74. http://dx.doi.org/10.1590/
S0066-782X1998001000002. 
PMid:10347931.
8. Clausell N, Daly PA, Molossi S, Lima 
VC, Adelman G, Gotlieb AI, et al. 
Histological and immunohistochemical 
characteristics of eccentric 
coronary artery lesions retrieved 
by atherectomy from cardiac 
transplant recipients. Cardiovasc 
Pathol. 1997;6(1):23-9. http://dx.doi.
org/10.1016/S1054-8807(96)00069-5.
PMid:25943569.
9. Doggrell SA, Brown L. Rat models 
of hypertension, cardiac hypertrophy 
and failure. Cardiovasc Res. 
1998;39(1):89-105. http://dx.doi.
org/10.1016/S0008-6363(98)00076-5. 
PMid:9764192.
10. Singh JP, Kandala J, Camm AJ. Non-
pharmacological modulation of the 
autonomic tone to treat heart failure. 
Eur Heart J. 2014;35(2):77-85. http://
dx.doi.org/10.1093/eurheartj/eht436. 
PMid:24174128.
11. Hasenfuss G. Animal models of 
human cardiovascular disease, heart 
failure and hypertrophy. Cardiovasc 
Res. 1998;39(1):60-76. http://dx.doi.
org/10.1016/S0008-6363(98)00110-2. 
PMid:9764190.
12. Azevedo ER, Parker JD. 
Parasympathetic control of cardiac 
sympathetic activity: normal ventricular 
function versus congestive heart 
failure. Circulation. 1999;100(3):274-
9. http://dx.doi.org/10.1161/01.
CIR.100.3.274. PMid:10411852.
13. European Society of Cardiology and 
the North American Society of Pacing 
and Electrophysiology. Heart rate 
variability: standards of measurement, 
physiological interpretation and clinical 
use. Circulation. 1996;93(5):1043-
65. http://dx.doi.org/10.1161/01.
CIR.93.5.1043. PMid:8598068.
14. Vanderlei LC, Pastre CM, Hoshi 
RA, Carvalho TD, Godoy MF. Basic 
notions of heart rate variability and 
its clinical applicability. Rev Bras 
Cir Cardiovasc. 2009;24(2):205-
17. http://dx.doi.org/10.1590/
S0102-76382009000200018. 
PMid:19768301.
15. National Research Council (NAP). 
Guide for the care and use of 
laboratory animals. Washington: 
NAP; 2018 [cited 2018 Jan 10]. 
Available from: http://www.nap.edu/
catalog/5140.html
16. Mostarda C, Rodrigues B, Vane M, 
Moreira ED, Rosa KT, Moraes-Silva 
IC, et al. Autonomic impairment after 
myocardial infarction: Role in cardiac 
remodeling and mortality. Clin Exp 
Pharmacol Physiol. 2010;37(4):447-
52. http://dx.doi.org/10.1111/j.1440-
1681.2009.05327.x. PMid:19878213.
17. Ishise H, Asanoi H, Ishizaka S, Joho 
S, Kameyama T, Umeno K, et al. Time 
course of sympathovagal imbalance 
and left ventricular dysfunction in 
conscious dogs with heart failure. 
J Appl Physiol. 1998;84(4):1234-
41. http://dx.doi.org/10.1152/
jappl.1998.84.4.1234. PMid:9516189.
18. Kompa AR, Summers RJ. Lidocaine 
and surgical modification reduces 
mortality in a rat model of cardiac 
failure induced by coronary artery 
ligation. J Pharmacol Toxicol Methods. 
2000;43(3):199-203. http://dx.doi.
org/10.1016/S1056-8719(00)00103-9. 
PMid:11257484.
19. Mill JG, Vassallo DV, Leite CM. Time 
course of changes in heart rate and 
sympathetic tone after coronary artery 
ligation in rats. Braz J Med Biol Res. 
1991;24(8):855-8. PMid:1797278.
20. De Angelis K, Leirner AA, Irigoyen 
MC, Cestari IA. Nonstimulated 
cardiomyoplasty improves 
hemodynamics in myocardial-infarcted 
rats. Artif Organs. 2001;25(11):939-
43. http://dx.doi.org/10.1046/j.1525-
1594.2001.06907.x. PMid:11903150.
21. Norman TD, Coers CR. Cardiac 
hypertrophy after coronary artery 
ligation. Arch Pathol. 1960;69:181-4. 
PMid:14427631.
22. Mill JG, Leite CM, Vassallo DV. Effects 
of sympathetic block on post-infarction 
cardiac hypertrophy and their impact 
on myocardial contractility. Arq 
Bras Cardiol. 1991;57(6):435-43. 
PMid:1840467.
23. Schwartz PJ, De Ferrari GM. 
Sympathetic-parasympathetic 
interaction in health and disease: 
abnormalities and relevance 
in heart failure. Heart Fail Rev. 
2011;16(2):101-7. http://dx.doi.
org/10.1007/s10741-010-9179-1. 
PMid:20577900.
24. Mill JG, Stefanon I, dos Santos 
L, Baldo MP. Remodeling in the 
ischemic heart: the stepwise 
progression for heart failure. Braz 
J Med Biol Res. 2011;44(9):890-8. 
http://seer.ufrgs.br/hcpaClin Biomed Res 2018;38(2)140
Nascimento et al.
http://dx.doi.org/10.1590/
S0100-879X2011007500096. 
PMid:21829898.
25. Mortara A, La Rovere MT, Signorini 
MG, Pantaleo P, Pinna G, Martinelli 
L, et al. Can power spectral analysis 
of heart rate variability identify a 
high risk subgroup of congestive 
heart failure patients with excessive 
sympathetic activation? A pilot study 
before and after heart transplantation. 
Br Heart J. 1994;71(5):422-30. http://
dx.doi.org/10.1136/hrt.71.5.422. 
PMid:8011405.
26. La Rovere MT, Specchia G, Mortara 
A, Schwartz PJ. Baroreflex sensitivity, 
clinical correlates, and cardiovascular 
mortality among patients with a first 
myocardial infarction: a prospective 
study. Circulation. 1988;78(4):816-
24. http://dx.doi.org/10.1161/01.
CIR.78.4.816. PMid:3168190.
27. Koike MK, Moreira ED, da Silva 
GJ, Consolim-Colombo FM, Ida 
F, Irigoyen MC, et al. Resetting of 
aortic baroreceptors in response 
to hypotension does not alter gain 
sensitivity. Clin Exp Pharmacol 
Physiol. 2006;33(8):679-84. 
http://dx.doi.org/10.1111/j.1440-
1681.2006.04431.x. PMid:16895539.
28. Rondon E, Brasileiro-Santos MS, 
Moreira ED, Rondon MU, Mattos 
KC, Coelho MA, et al. Exercise 
training improves aortic depressor 
nerve sensitivity in rats with 
ischemia-induced heart failure. 
Am J Physiol Heart Circ Physiol. 
2006;291(6):H2801-6. http://dx.doi.
org/10.1152/ajpheart.01352.2005. 
PMid:16798817.
29. Aires R, Pimentel EB, Forechi L, 
Dantas EM, Mill J. Time course of 
changes in heart rate and blood 
pressure variability in rats with 
myocardial infarction. Braz J Med Biol 
Res. 2017;50(1):e5511. http://dx.doi.
org/10.1590/1414-431x20165511. 
PMid:28076450.
30. Kinugawa T, Dibner-Dunlap ME. 
Altered vagal and sympathetic 
control of heart rate in left ventricular 
dysfunction and heart failure. Am 
J Physiol. 1995;268(2):R310-6. 
PMid:7864224.
Received: Jan 10, 2018 
Accepted: June 12, 2018
